Menu
Recruiting NCT07354048

Impact Of Thyroid Dysfunction on Liver Function Tests

Observational Thyroid Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Control group, Patients with hypothyroidism or hyperthyroidism that are controlled on treatment, Patients with hypothyroidism or hyperthyroidism that are not controlled on treatment, Patients with hypothyroidism or hyperthyroidism that are firstly discovered.
Who it may be relevant to
Registry conditions: Thyroid Disease. Basic parameters: 20 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Impact Of Thyroid Dysfunction on Liver Function Tests In Sohag University Hospital

Overview

This study aims to evaluate the effect of thyroid dysfunction on liver function tests.

Interventions

  • Other Control group
    Healthy people
  • Other Patients with hypothyroidism or hyperthyroidism that are controlled on treatment
    This group includes patients with hypothyroidism or hyperthyroidism that are controlled on treatment
  • Other Patients with hypothyroidism or hyperthyroidism that are not controlled on treatment
    This group includes patients with hypothyroidism or hyperthyroidism that are not controlled on treatment
  • Other Patients with hypothyroidism or hyperthyroidism that are firstly discovered
    This group includes patients with hypothyroidism or hyperthyroidism that are firstly discovered

Primary outcome measures

  • Measuring total bilirubin level in patients with thyroid dysfunction diseases [Time frame: 1 months]

Eligibility criteria

Inclusion criteria

  • All patients between the ages of 20-60 years old either with Hypothyroidism or Hyperthyroidism (controlled on treatment or not) and firstly diagnosed Hypothyroidism or Hyperthyroidism.
  • Euthyroid controls (clinically healthy control subjects were recruited from the general population with the same socio-economic status with the subjects.)

Exclusion criteria

  • Patients aged < 20 years old.
  • Patients With Liver Disease.
  • Pregnant and lactating women.
  • Patients with severe infections or sepsis.
  • Patients with Heart Disease.
  • Patients who on drugs that can affect liver function such as phenothiazine, phenylbutazone, methyldopa, among others.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-control

Study locations

Egypt · 1 center
  • Sohag University Hospital — Sohag

Publications

  • Boelaert K, Franklyn JA. Thyroid hormone in health and disease. J Endocrinol. 2005 Oct;187(1):1-15. doi: 10.1677/joe.1.06131. PMID 16214936
  • Malik R, Hodgson H. The relationship between the thyroid gland and the liver. QJM. 2002 Sep;95(9):559-69. doi: 10.1093/qjmed/95.9.559. PMID 12205333
  • Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002 Feb;23(1):38-89. doi: 10.1210/edrv.23.1.0455. PMID 11844744

Identifiers

NCT: NCT07354048 · Soh-Med--25-7-9MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗